Countrywide insecticide resistance monitoring and first report of the presence of the L1014S knock down resistance in Niger, West Africa.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
16 Dec 2022
Historique:
received: 11 06 2022
accepted: 09 12 2022
entrez: 15 12 2022
pubmed: 16 12 2022
medline: 20 12 2022
Statut: epublish

Résumé

Mass distribution of insecticide-treated nets (ITNs) is the principal malaria vector control strategy adopted by Niger. To better inform on the most appropriate ITN to distribute, the National Malaria Control Programme (NMCP) of Niger and its partners, conducted insecticide resistance monitoring in selected sites across the country. The susceptibility of Anopheles gambiae sensu lato (s.l.) to chlorfenapyr and pyrethroid insecticides was investigated in a total of sixteen sites in 2019 and 2020, using 2-5-day-old adults reared from wild collected larvae per site. The susceptibility status, pyrethroid resistance intensity at 5 and 10 times the diagnostic concentrations, and piperonyl butoxide (PBO) synergism with diagnostic concentrations of deltamethrin, permethrin and alpha-cypermethrin were assessed using WHO bioassays. Two doses (100 and 200 µg/bottle) of chlorfenapyr were tested using the CDC bottle assay method. Species composition and allele frequencies for knock-down resistance (kdr-L1014F and L1014S) and acetylcholinesterase (ace-1 G119S) mutations were further characterized using polymerase chain reaction (PCR). High resistance intensity to all pyrethroids tested was observed in all sites except for alpha-cypermethrin in Gaya and Tessaoua and permethrin in Gaya in 2019 recording moderate resistance intensity. Similarly, Balleyara, Keita and Tillabery yielded moderate resistance intensity for alpha-cypermethrin and deltamethrin, and Niamey V low resistance intensity against deltamethrin and permethrin in 2020. Pre-exposure to PBO substantially increased susceptibility with average increases in mortality between 0 and 70% for tested pyrethroids. Susceptibility to chlorfenapyr (100 µg/bottle) was recorded in all sites except in Tessaoua and Magaria where susceptibility was recorded at the dose of 200 µg/bottle. Anopheles coluzzii was the predominant malaria vector species in most of the sites followed by An. gambiae sensu stricto (s.s.) and Anopheles arabiensis. The kdr-L1014S allele, investigated for the first time, was detected in the country. Both kdr-L1014F (frequencies [0.46-0.81]) and L1014S (frequencies [0.41-0.87]) were present in all sites while the ace-1 G119S was between 0.08 and 0.20. The data collected will guide the NMCP in making evidence-based decisions to better adapt vector control strategies and insecticide resistance management in Niger, starting with mass distribution of new generation ITNs such as interceptor G2 and PBO ITNs.

Sections du résumé

BACKGROUND BACKGROUND
Mass distribution of insecticide-treated nets (ITNs) is the principal malaria vector control strategy adopted by Niger. To better inform on the most appropriate ITN to distribute, the National Malaria Control Programme (NMCP) of Niger and its partners, conducted insecticide resistance monitoring in selected sites across the country.
METHODS METHODS
The susceptibility of Anopheles gambiae sensu lato (s.l.) to chlorfenapyr and pyrethroid insecticides was investigated in a total of sixteen sites in 2019 and 2020, using 2-5-day-old adults reared from wild collected larvae per site. The susceptibility status, pyrethroid resistance intensity at 5 and 10 times the diagnostic concentrations, and piperonyl butoxide (PBO) synergism with diagnostic concentrations of deltamethrin, permethrin and alpha-cypermethrin were assessed using WHO bioassays. Two doses (100 and 200 µg/bottle) of chlorfenapyr were tested using the CDC bottle assay method. Species composition and allele frequencies for knock-down resistance (kdr-L1014F and L1014S) and acetylcholinesterase (ace-1 G119S) mutations were further characterized using polymerase chain reaction (PCR).
RESULTS RESULTS
High resistance intensity to all pyrethroids tested was observed in all sites except for alpha-cypermethrin in Gaya and Tessaoua and permethrin in Gaya in 2019 recording moderate resistance intensity. Similarly, Balleyara, Keita and Tillabery yielded moderate resistance intensity for alpha-cypermethrin and deltamethrin, and Niamey V low resistance intensity against deltamethrin and permethrin in 2020. Pre-exposure to PBO substantially increased susceptibility with average increases in mortality between 0 and 70% for tested pyrethroids. Susceptibility to chlorfenapyr (100 µg/bottle) was recorded in all sites except in Tessaoua and Magaria where susceptibility was recorded at the dose of 200 µg/bottle. Anopheles coluzzii was the predominant malaria vector species in most of the sites followed by An. gambiae sensu stricto (s.s.) and Anopheles arabiensis. The kdr-L1014S allele, investigated for the first time, was detected in the country. Both kdr-L1014F (frequencies [0.46-0.81]) and L1014S (frequencies [0.41-0.87]) were present in all sites while the ace-1 G119S was between 0.08 and 0.20.
CONCLUSION CONCLUSIONS
The data collected will guide the NMCP in making evidence-based decisions to better adapt vector control strategies and insecticide resistance management in Niger, starting with mass distribution of new generation ITNs such as interceptor G2 and PBO ITNs.

Identifiants

pubmed: 36522727
doi: 10.1186/s12936-022-04410-4
pii: 10.1186/s12936-022-04410-4
pmc: PMC9756763
doi:

Substances chimiques

decamethrin 2JTS8R821G
cypermethrin 1TR49121NP
chlorfenapyr NWI20P05EB
Permethrin 509F88P9SZ
Acetylcholinesterase EC 3.1.1.7
N-methylchlorphentermine 78558-95-9
Pyrethrins 0
Insecticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

385

Informations de copyright

© 2022. The Author(s).

Références

Malar J. 2011 Jan 25;10:16
pubmed: 21266037
Parasit Vectors. 2013 Feb 22;6:41
pubmed: 23433176
Annu Rev Entomol. 2015 Jan 7;60:537-59
pubmed: 25564745
Wellcome Open Res. 2017 Feb 9;2:8
pubmed: 28317032
Am J Trop Med Hyg. 2010 Apr;82(4):566-73
pubmed: 20348500
Malar J. 2009 Dec 17;8:299
pubmed: 20015411
PLoS One. 2011;6(9):e24336
pubmed: 21915314
J Am Mosq Control Assoc. 1999 Mar;15(1):53-9
pubmed: 10342269
PLoS One. 2016 Sep 02;11(9):e0162210
pubmed: 27588945
PLoS One. 2007 Nov 28;2(11):e1243
pubmed: 18043750
Biotechniques. 1998 Oct;25(4):588-90, 592
pubmed: 9793639
Trends Parasitol. 2011 Feb;27(2):91-8
pubmed: 20843745
Annu Rev Entomol. 2000;45:371-91
pubmed: 10761582
Malar J. 2008 Aug 25;7:163
pubmed: 18724871
Sci Rep. 2017 Sep 11;7(1):11091
pubmed: 28894186
Med Mal Infect. 2017 Oct;47(6):415-423
pubmed: 28648613
Malar J. 2017 Aug 17;16(1):342
pubmed: 28818077
Malar J. 2017 Aug 16;16(1):340
pubmed: 28814307
Insect Mol Biol. 2000 Oct;9(5):491-7
pubmed: 11029667
Parasit Vectors. 2011 Jun 16;4:107
pubmed: 21679391
Acta Trop. 2013 Feb;125(2):123-7
pubmed: 23128044
Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):iv-vii
pubmed: 11425185
Malar J. 2019 May 24;18(1):181
pubmed: 31126311
Malar J. 2017 Feb 20;16(1):85
pubmed: 28219387
Trends Parasitol. 2016 Mar;32(3):187-196
pubmed: 26826784
J Am Mosq Control Assoc. 1987 Jun;3(2):302-3
pubmed: 3333059
Parassitologia. 1999 Sep;41(1-3):319-22
pubmed: 10697876
Malar J. 2020 Dec 9;19(1):454
pubmed: 33298071
Emerg Infect Dis. 2012 Sep;18(9):1508-11
pubmed: 22932478
Trends Parasitol. 2009 May;25(5):213-9
pubmed: 19369117
Elife. 2016 Aug 22;5:
pubmed: 27547988
J Infect Dis. 2021 Apr 27;223(12 Suppl 2):S81-S90
pubmed: 33906223
J Am Mosq Control Assoc. 1998 Jun;14(2):159-64
pubmed: 9673916
Malar J. 2016 Aug 24;15(1):426
pubmed: 27553959
Med Vet Entomol. 2006 Mar;20(1):27-32
pubmed: 16608487
Am J Trop Med Hyg. 2002 Dec;67(6):617-22
pubmed: 12518852
Emerg Infect Dis. 2014 Oct;20(10):1691-6
pubmed: 25279965
Lancet Glob Health. 2021 Sep;9(9):e1325-e1331
pubmed: 34216565
Malar J. 2008 Apr 29;7:74
pubmed: 18445265
Malar J. 2008 Sep 25;7:189
pubmed: 18817574
Malar J. 2019 Jul 17;18(1):243
pubmed: 31315614
Malar J. 2008 Aug 28;7:168
pubmed: 18755020
Insect Mol Biol. 1998 May;7(2):179-84
pubmed: 9535162
PLoS One. 2011 Jan 12;6(1):e16066
pubmed: 21264325
Lancet Infect Dis. 2018 Jun;18(6):640-649
pubmed: 29650424
Malar J. 2006 Feb 22;5:16
pubmed: 16504072
Parasit Vectors. 2014 Oct 07;7:450
pubmed: 25292318
Insect Mol Biol. 2004 Feb;13(1):1-7
pubmed: 14728661
Trials. 2019 Jun 3;20(1):321
pubmed: 31159887

Auteurs

Hadiza Soumaila (H)

PMI VectorLink Project, Niamey, Niger.

Boubé Hamani (B)

National Malaria Control Programme, Niamey, Niger.

Ibrahim Issa Arzika (II)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Amadou Soumana (A)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Abdoulaye Daouda (A)

National Malaria Control Programme, Niamey, Niger.

Fatoumata Abdoulaye Daouda (FA)

National Malaria Control Programme, Niamey, Niger.

Souleymane Mahaman Iro (SM)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Samira Gouro (S)

National Malaria Control Programme, Niamey, Niger.

Maman Sani Zaman-Allah (MS)

National Malaria Control Programme, Niamey, Niger.

Izamné Mahamadou (I)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Saadou Kadri (S)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Noura Maman Salé (NM)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Wilfried Hounkanrin (W)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Boubacar Mahamadou (B)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Halima Naroua Zamaka (HN)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Rabiou Labbo (R)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Ibrahim Maman Laminou (IM)

Centre de Recherche Médicale et Sanitaire, Niamey, Niger.

Hadiza Jackou (H)

National Malaria Control Programme, Niamey, Niger.

Sabiti Idrissa (S)

National Malaria Control Programme, Niamey, Niger.

Eric Coulibaly (E)

U.S. President's Malaria Initiative, USAID, Niamey, Niger.

Zilahatou Bahari-Tohon (Z)

U.S. President's Malaria Initiative, USAID, Niamey, Niger.

Els Mathieu (E)

U.S. President's Malaria Initiative, USAID, Niamey, Niger.
U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

Jenny Carlson (J)

Entomology Branch, U.S. President's Malaria Initiative, Atlanta, GA, USA.

Ellen Dotson (E)

U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

Taiwo Samson Awolola (TS)

U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.

Cecilia Flatley (C)

PMI VectorLink Project, Washington, DC, USA.

Joseph Chabi (J)

PMI VectorLink Project, Washington, DC, USA. Joseph_Chabi@pmivectorlink.com.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH